JCDSA  Vol.4 No.5 , December 2014
Patient Reported Frequency of Lupus Flare: Associations with Foundation Makeup and Sunscreen Use
Abstract: Objective: To test the hypothesis that usage of foundation makeup (FM) and sunscreen lotion (SS), used individually or in combination, is associated with significant changes in the likelihood of lupus symptom exacerbation. Methods: Self-reported flare days (SRF) and use of FM and SS products, were retrospectively examined in 80 Caucasian Australian women with ACR classified SLE for a year. Negative binomial regression modelled SRF days (outcome) against independent FMSS variable and covariates: age; diagnosis years; outdoor hours; BMI; stress; immune therapy medication (ITM) use. Results: Statistically significant inverse associations between SRF days and FMSS use were found. Protective effects were statistically significant (p < 0.05) for combined FMSS exposure days (OR 0.998, CI 0.997 - 1.0) and FM alone (OR 0.603, CI 0.363 - 1.0). Significant associations consistent with increased SRF risk were seen in sub-analysis models for participants taking ITM: univariate model (OR 1.968, p = 0.03); multivariate model for FMSS (OR 2.11, CI 1.161 - 3.835); FM days (OR 1.855, CI 1.023 - 3.364). Results show SRF day reduction of 0.15% for each day of product exposure. Conclusion: Study results highlight protective effects of wearing FM with or without SS. This reduction in flare days ultimately has potential to improve quality of life in SLE patients.
Cite this paper: Squance, M. , Reeves, G. , Attia, J. , (2014) Patient Reported Frequency of Lupus Flare: Associations with Foundation Makeup and Sunscreen Use. Journal of Cosmetics, Dermatological Sciences and Applications, 4, 344-354. doi: 10.4236/jcdsa.2014.45046.

[1]   Hayter, S.M. and Cook, M.C. (2012) Updated Assessment of the Prevalence, Spectrum and Case Definition of Autoimmune Disease. Autoimmunity Reviews, 11, 754-765.

[2]   Danchenko, N., Satia, J.A. and Anthony, M.S. (2006) Epidemiology of Systemic Lupus Erythematosus: A Comparison of Worldwide Disease Burden. Lupus, 15, 308-318.

[3]   Cooper, G.S. and Stroehla, B.C. (2003) The Epidemiology of Autoimmune Diseases. Autoimmunity Reviews, 2, 119-125.

[4]   Jacobson, D.L., Gange, S.J., Rose, N.R. and Graham, N.M. (1997) Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States. Clinical Immunology and Immunopathology, 84, 223-243.

[5]   Pons-Estel, G.J., Alarcon, G.S., Scofield, L., Reinlib, L. and GS, C. (2010) Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 39, 257-268.

[6]   Dooley, M.A. and Hogan, S.L. (2003) Environmental Epidemiology and Risk Factors for Autoimmune Disease. Current Opinion in Rheumatology, 15, 99-103.

[7]   Foster, M.W. and Aston, C.E. (2003) A Practice Approach for Identifying Previously Unsuspected Environmental Contributors to Systemic Lupus Erythematosus and Other Complex Diseases. Environmental Health Perspectives, 111, 593-597.

[8]   Zandman-Goddard, G., Solomon, M., Rosman, Z., Peeva, E. and Shoenfeld, Y. (2012) Environment and Lupus-Related Diseases. Lupus, 21, 241-250.

[9]   Mayes, M.D. (1999) Epidemiologic Studies of Environmental Agents and Systemic Autoimmune Diseases. Environmental Health Perspectives, 107, 743-748.

[10]   Hess, E.V. (1999) Are There Environmental Forms of Systemic Autoimmune Diseases? Environmental Health Perspectives, 107, 709-711.

[11]   Cooper, G.S., Gilbert, K.M., Greidinger, E.L., James, J.A., Pfau, J.C., Reinlib, L., et al. (2008) Recent Advances and Opportunities in Research on Lupus: Environmental Influences and Mechanisms of Disease. Environmental Health Perspectives, 116, 695-702.

[12]   Gourley, M. and Miller, F.W. (2007) Mechanisms of Disease: Environmental Factors in the Pathogenesis of Rheumatic Disease. Nature Reviews Rheumatology, 3, 172-180.

[13]   Cooper, G.S., Treadwell, E.L., St. Clair, E.W., Gilkeson, G.S. and Dooley, M.A. (2007) Sociodemographic Associations with Early Disease Damage in Patients with Systemic Lupus Erythematosus. Arthritis Care and Research, 57, 993-999.

[14]   Cooper, G.S., Wither, J., Bernatsky, S., Claudio, J.O., Clarke, A., Rioux, J.D., et al. (2010) Occupational and Environmental Exposures and Risk of Systemic Lupus Erythematosus: Silica, Sunlight, Solvents. Rheumatology (Oxford), 49, 2172-2180.

[15]   Hess, E.V. (2002) Environmental Chemicals and Autoimmune Disease: Cause and Effect. Toxicology, 181-182, 65-70.

[16]   Dodson, R.E., Nishioka, M., Standley, L.J., Perovich, L.J., Brody, J.G. and Rudel, R.A. (2012) Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products. Environmental Health Perspectives, 120, 935-943.

[17]   Altman, R.G., Morello-Frosch, R., Brody, J.G., Rudel, R., Brown, P. and Averick, M. (2008) Pollution Comes Home and Gets Personal: Women’s Experience of Household Chemical Exposure. Journal of Health and Social Behavior, 49, 417-435.

[18]   Rheumatology ACo (2005) 1997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus. Classification Criteria for Diagnosis of Systemic Lupus Erythematosus.

[19]   Squance, M.L., Guest, M., Reeves, G., Attia, J. and Bridgman, H. (2014) Exploring Lifetime Occupational Exposure and SLE Flare: A Patient-Focussed Pilot Study. Lupus Science & Medicine, 1, e000023.

[20]   Association, W.M. (2008) World Medical Association Declaration of Helsinki. 59th WMA General Assembly, Seoul, October 2008.

[21]   Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., et al. (1983) New Diagnostic Criteria for Multiple Sclerosis: Guidelines for Research Protocols. Annals of Neurology, 13, 227-231.

[22]   Borges, M.C., Martini, L.A. and Rogero, M.M. (2011) Current Perspectives on Vitamin D, Immune System, and Chronic Diseases. Nutrition, 27, 399-404.

[23]   Guillot, X., Semerano, L., Saidenberg-Kermanac’h, N., Falgarone, G. and Boissier, M.C. (2010) Vitamin D and Inflammation. Joint Bone Spine, 77, 552-557.

[24]   Parravicini, V. and Caserta, S. (2010) The Immunomodulatory Roles of Vitamin D: New Tricks for an Old Dog. Molecular Interventions, 10, 204-208.

[25]   Zhang, H.L. and Wu, J. (2010) Role of Vitamin D in Immune Responses and Autoimmune Diseases, with Emphasis on its Role in Multiple Sclerosis. Neuroscience Bulletin, 26, 445-454.

[26]   Carr, F.N., Nicassio, P.M., Ishimori, M.L., Moldovan, I., Katsaros, E., Torralba, K., et al. (2011) Depression Predicts Self-Reported Disease Activity in Systemic Lupus Erythematosus. Lupus, 20, 80-84.

[27]   Griffiths, B., Mosca, M. and Gordon, C. (2005) Assessment of Patients with Systemic Lupus Erythematosus and the Use of Lupus Disease Activity Indices. Best Practice & Research Clinical Rheumatology, 19, 685-708.

[28]   Leong, K.P., Chong, E.Y., Kong, K.O., Chan, S.P., Thong, B.Y., Lian, T.Y., et al. (2010) Discordant Assessment of Lupus Activity between Patients and Their Physicians: The Singapore Experience. Lupus, 9, 100-106.

[29]   Yen, J.C., Abrahamowicz, M., Dobkin, P.L., Clarke, A.E., Battista, R.N. and Fortin, P.R. (2003) Determinants of Discordance between Patients and Physicians in Their Assessment of Lupus Disease Activity. The Journal of rheumatology, 30, 1967-1976.

[30]   Obermoser, G. and Zelger, B. (2008) Triple Need for Photoprotection in Lupus Erythematosus. Lupus, 17, 525-527.

[31]   Wang, J., Kay, A.B., Fletcher, J., Formica, M.K. and McAlindon, T.E. (2008) Is Lipstick Associated with the Development of Systemic Lupus Erythematosus (SLE)? Clinical Rheumatology, 27, 1183-1187.

[32]   Ting, W.W. and Sontheimer, R.D. (2001) Local Therapy for Cutaneous and Systemic Lupus Erythematosus: Practical and Theoretical Considerations. Lupus, 10, 171-184.

[33]   Ilchyshyn, L., Hawk, J.L. and Millard, T.P. (2008) Photoprotection: Does It Work? Lupus, 17, 705-707.

[34]   Kuhn, A., Gensch, K., Haust, M., Meuth, A.M., Boyer, F., Dupuy, P., et al. (2011) Photoprotective Effects of A Broad-Spectrum Sunscreen in Ultraviolet-Induced Cutaneous Lupus Erythematosus: A Randomized, Vehicle-Controlled, Double-Blind Study. Journal of the American Academy of Dermatology, 64, 37-48.

[35]   Vila, L.M., Mayor, A.M., Valentin, A.H., Rodriguez, S.I., Reyes, M.L., Acosta, E., et al. (1999) Association of Sunlight Exposure and Photoprotection Measures with Clinical Outcome in Systemic Lupus Erythematosus. Puerto Rico Health Sciences Journal, 18, 89-94.

[36]   Boehncke, W.H., Ochsendorf, F., Paeslack, I., Kaufmann, R. and Zollner, T.M. (2002) Decorative Cosmetics Improve the Quality of Life in Patients with Disfiguring Skin Diseases. European Journal of Dermatology, 12, 577-580.

[37]   Shear, N.H. and Graff, L. (1987) Camouflage Cosmetics in Dermatologic Therapy. Canadian Family Physician, 33, 2343-2346.

[38]   Autier, P., Boniol, M. and Dore, J.F. (2007) Sunscreen Use and Increased Duration of Intentional Sun Exposure: Still a Burning Issue. International Journal of Cancer, 121, 1-5.

[39]   Manova, E., von Goetz, N., Hauri, U., Bogdal, C. and Hungerbuhler, K. (2012) Organic UV Filters in Personal Care Products in Switzerland: A Survey of Occurrence and Concentrations. International Journal of Hygiene and Environmental Health, 216, 508-514.

[40]   NSW Government (2011) Research CfEa. New South Wales Population Health Survey 2010. Centre for Epidemiology and Research PHD, NSW Department of Health, Australia.

[41]   Schlumpf, M., Kypke, K., Wittassek, M., Angerer, J., Mascher, H., Mascher, D., et al. (2010) Exposure Patterns of UV Filters, Fragrances, Parabens, Phthalates, Organochlor Pesticides, PBDEs, and PCBs in Human Milk: Correlation of UV Filters with Use of Cosmetics. Chemosphere, 81, 1171-1183.

[42]   Nohynek, G.J., Lademann, J., Ribaud, C. and Roberts, M.S. (2007) Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety. Critical Reviews in Toxicology, 37, 251-277.

[43]   NLM (2013) Household Products Database.

[44]   Calafat, A.M., Wong, L.Y., Ye, X., Reidy, J.A. and Needham, L.L. (2008) Concentrations of the Sunscreen Agent Benzophenone-3 in Residents of the United States: National Health and Nutrition Examination Survey 2003-2004. Environmental Health Perspectives, 116, 893-897.

[45]   Hale, E.D., Treharne, G.J., Norton, Y., Lyons, A.C., Douglas, K.M., Erb, N., et al. (2006) “Concealing the Evidence”: The Importance of Appearance Concerns for Patients with Systemic Lupus Erythema- tosus. Lupus, 15, 532-540.